The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters or search function to help find relevant consultations.
Consultations
Search open and closed consultations on the way we regulate medicines, medical devices and biologicals.
- You can also find, read and respond to recent consultations, submissions and decisions at the TGA Consultation hub.
- Find more scheduling consultations on the Poisons Standard in our Interim decisions.
- Archived consultations and reviews can be viewed on the National Library of Australia Trove site.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (77)
- Therapeutic goods regulation (18)
- Prescription medicines (15)
- Over the counter (OTC) medicines (14)
- Legislation (12)
- Complementary medicines (11)
- Advisory bodies and committees (10)
- Non-prescription medicines (10)
- Listed medicines (9)
- Labelling and packaging (6)
- Manufacturing (6)
- In Vitro Diagnostic medical devices (IVDs) (4)
- Medical devices safety (4)
- Advertising (3)
- Biological medicines (3)
- Medicine safety (3)
- Sunscreens (3)
- Australian Register of Therapeutic Goods (ARTG) (2)
- Fees and payments (2)
- Import and export (2)
- Safety (2)
- Shortages (2)
- Artificial Intelligence (AI) (1)
- Assessed listed medicines (1)
- Blood and blood components (1)
- Clinical trials (1)
- Disinfectants/Sterilants (1)
- Medicinal cannabis hub (1)
- Registered complementary medicines (1)
- Unique Device Identification (UDI) hub (1)
- Vaping hub (1)
Search
251 result(s) found, displaying 101 to 125
-
ConsultationThe TGA is seeking feedback on proposed advisory statements for OTC medicines containing methyl salicylate for inclusion in RASML. Closing date: 18 May 2021
-
ConsultationOutcomes of the consultation and submissions received have now been published
-
ConsultationOutcomes of the consultation and submissions received have now been published
-
ConsultationOutcomes of the consultation and submissions received have now been published
-
ConsultationView the outcomes of public consultation on building a more robust medicine supply
-
ConsultationThe IMDRF working group is seeking comments from interested parties on the proposed guidance document. Closing date: 19 April 2021
-
ConsultationTGA is seeking comments on whether the Australian medical device regulatory framework should be aligned to the EU framework for medical devices containing nanomaterials. Closing date: 9 April 2021
-
ConsultationTGA is consulting on a proposed standard for vaporiser nicotine products (e.g. nicotine e-liquids). Closing date: 31 March 2021
-
ConsultationThe closing date has been extended until 30 March 2021.
-
ConsultationThis consultation is to obtain feedback in relation to proposals to provide clarity on residual claims for disinfectants. Closing date: 26 March 2021
-
ConsultationThe TGA is seeking comments on the proposed fees and charges for the 2021-22 financial year. Closing date: 17 March 2021
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 4-5 November 2020 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationTGA is seeking feedback on a proposal to streamline how information about certain therapeutic goods formulations is entered into TGA electronic systems when seeking market approval. Closing date: 24 February 2021
-
ConsultationA submission summary on the Australian Regulations definition of CCS consultation is available on our consultation hub
-
ConsultationA further update by the TGA on the proposed reforms to medicinal cannabis, labelling and packaging requirements.
-
ConsultationProposed amendments to the Poisons Standard. Closing date: 27 January 2020
-
ConsultationThe closing date for this consultation has been extended until 24 December 2020
-
ConsultationThe TGA (together with all other working group members) invite interested parties to comment on the document. Closing date: 11 December 2020
-
ConsultationOutcome of the Proposed enhancements to adverse event reporting for medical devices consultation paper.
-
ConsultationThis consultation is for an interim decision to amend the scheduling of nicotine in the current Poisons Standard, following advice sought at the 23 June 2020 meeting of the Advisory Committee on Medicines and Chemicals Scheduling in joint session (Joint ACMS-ACCS #25, June 2020).
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the scheduling in the Poisons Standard, following advice sought at the 23-25 June 2020 meetings of the Advisory Committee on Medicines Scheduling (ACMS), and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationConsultation: Permissible ingredients annual changes 2020-21
-
ConsultationThe Secretary invites public submissions on scheduling proposals. Closing date: 28 September 2020
-
ConsultationThe Therapeutic Goods Administration (TGA) is seeking feedback on proposed requirements for serialisation and the use of data matrix codes on the labels of certain medicines in the Australian supply chain.
-
ConsultationDraft IMDRF document. Closing date: 26 May 2020